Table Of Content

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 29. No. 5/6, December 2002 (© 2003) Author Index Volume 29 Aarons, Leon, 67 Gabrielson, Johan, 365 Pui, Ching-Hon, 171 Abelo, Angela, 365 Gieschke, Ronald R., 25 Pyszczynski, Nancy A., 1 Almon, Richard, 1, 103 Girard, Pascal, 339 Amann, Anton, 189 Gisleskog, Per O., 473 Ramakrishnan, Rohini, 1 Anissimov, Yuri G., 131 Gourlay, Steven G., 49, 384 Reigner, Bruno G., 25 Graham, Gordon, 67 Relling, Mary V., 171 Beal, Stuart L., 403, 473 Gries, Jean-Michel, 384 Roberts. Michael S., 131 Bellaz2i, R. 445 Gupta, Suneel K., 67 Rocchetti, M., 445 Benowitz, Neal L., 49, 384 Best. Nicky, 271 Hauschke, Dieter, 89, Schaedeli. Franziska, 49 Blesch, K. S., 25 Holstein, Bjorn, 365 Schoemaker, Rik C., 157 Blood, Peter, 99 Shi, Wei. 103 Boissel, Jean-Pierre, 339 Jonsson, E. Niclas, 252, 411 Spiegelhalter, David, 271 Bouw, Rene, 252 Jusko, William J., 1, 103,311 Steimer, Jean-Louis, 25 Brandenburg, Emily H., 103 Straubinger, Robert M., 103 Buijs, Madelon M., 157 Karlsson, Mats, 252, 365, Styblo, Miroslav, 207 Burggraaf, Jacobus. 157 411,473 TenHoor, Christopher N., Kenyon. Elaina M., 207 415 Chaubad, Sylvie, 339 Krzyzanski, Wojciech, 311 Thomas, Andrew, 271 Chow Shein-Chung, 101 Tuk, Bert. 235 Cohen, Adam F., 157 Lunn, David J., 271 Vaishnaw, Akshay K., 415 Danhof, Meindert, 235 Magni. Paulo, 445 Van Gool, Toon, 235 Dedik, Ladislav, 427 Verotta, Davide. 49, 384 De Nicolao, G., 445 Nigrovic, Vladimir, 189 Dubois, Debra C., 1, 103 Nony, Patrice, 339 Wahlby, Ulrika M., 252, 411 C)uri§aova, Maria, 427 Wakefield, Jon, 271 Panetta, John Carl, 171 Wang, Hansheng, 101 Easterling, Michael R., 207 Pijl, Hanno, 157 Wilkinson, Mark 171 Eriksson, Ulf G., 365 Pitsiu, Maria, 49, 384 Evans, Marina V., 207 Poggesi, 1.. 445 Zhang, Shuzhong, 103 509 1567-567X/02/1200-0509/0 © 2003 Plenum Publishing Corporation Journal of Pharmacokinetics and Pharmacodynamics, Vol. 29, No. 5/6, December 2002 (© 2003) Subject Index Volume 29 5-FU, 25 Endogenous compounds, Nonlinear hierarchical 157 models, 67 Alefacept. 415 Etoposide, 171 NONMEM, 25, 157, 252, Allosteric modulation, 235 339, 365 Angina pectoris, 339 Factor VII, 427 Normal and lognormal Arsenic, 207 Frequentist prior, 427 distribution, 89 Arterial-venous dilTerences, 384 Gibbs sampling, 271 Omeprazole, 365 Arterio-venous, 49 Optimal dosage regimen, 67 AUC, 445 H + K + ATPase inhibitor, Optimal sampling strategies, 171 365 Bayesian analysis, 67 Oxybutymn, 67 Hemophilia A, 427 Bayesian estimation, 445 Hepatic disposition, 131 Parallel design, 89 Bayesian hierarchical Hepatic elimination. 131 Pharmacodynamics, 1, 49, models, 271 Human LFA-3/IgG, 415 67, 103, 311 Bayesian methods, 171 Pharmacogenomics, 1, 103 Bayesian prior, ? Indirect response, 157 Pharmacokinetic model, 207 Benzodiazepine BXl Interindividual variability, Pharmacokinetics 171, 415, receptor, 235 252 427, 445 Bioavailability, 384 Inverse Gaussian PK Bugs. 271 Bioequivalence, 89 distribution, 131 PK/PD modeling, 157, 235, Bradycardic agent, 339 365 BUGS, 271 Leukopenia, 311 Population analysis, 271, Capecitabine, 25 Lifespan-based indirect 445 Chemotherapeutic agents, response models, 311 Population approach, 445 311 Likelihood ratio test, 252 Population Chewing tobacco, 384 Limited sampling strategies, pharmacokinetics, 25 Cigarette smoking, 384 171 Population PKPD, 339 Postsynaptic receptors, 189 Clinical trial simulation, 339 Compartmental model, 131 Markov chain Monte Carlo, Prior information, 445 Computer simulation, 427 271,445 Psoriasis, 415 Convolution, 384 Methylprednisolone, 1 Residual variability, 252 Corticosteroids, 103 Microarrays, 103 Route of administration, Crossover design, 89 Monte Carlo simulation, 415 171 Database resampling, 339 Sample size, 89 Decision analysis, 67 Neuromuscular blocking Secondary vascular Dispersion model, 131 drugs, 189 component, 131 Dosage adjustment, 427 Neuromuscular Sensitivity analysis, 207 transmission, 189 Simulation of Effect compartment, 157 Nicotine, 49, 384 neuromuscular block, 189 Electro encephalogram, 235 Non steady state. 49 Skeletal muscle, 189 511 1567-567X/02/1200-0511/0 © 2003 Plenum Publishing Corporauon 512 Subject Index Volume 29 Smokeless tobacco, 384 System approach, 427 Toxicokinetics, 445 Snuff, 384 Tyrosine aminotransferase, 1 Steele’s equations, 157 T lymphocytes, 415 WinBUGS, 271 Stimulus-effect relationship, Tobacco, 384 235 Tolerance models, 49 Xenobiotics, 445 ] I ! t 1 1 I I